Skip to main content

Table 2 Reasons for exclusion after positive response

From: Efficacy of tibolone and raloxifene for the maintenance of skeletal muscle strength, bone mineral density, balance, body composition, cognitive function, mood/depression, anxiety and quality of life/well-being in late postmenopausal women ≥ 70 years: Study design of a randomized, double-blind, double-dummy, placebo-controlled, single-center trial

Exclusion reason:

Total:

Subject does not want to

79

Already involved in another study

2

BMI > 33 or < 18

28

Cardiovascular disease

42

Hypertension

3

Thrombo-embolic disease

33

Malignancy

26

COPD

1

Liver problem

2

Decreased functionalability

3

On hormone replacement therapy

22

Contra-indicated medication

46

Parkinsonism

1

Osteoporosis

1

Two-sided hip prothesis

5

Moved to Spain/Belgium

2

General practitioner advised not to participate

1

Total

294